Daiqing Liao

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

St Segment Elevation Myocardial Infarction

Endoplasmic Reticulum

Histone Deacetylase

Renal Cell Carcinoma

Top Venues

Journal of medicinal chemistry

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Nina Erwin, Umasankar De, Yufeng Xiao, Lei Wang, Chandra Maharjan, Xiaoshu Pan, Nikee Awasthee, Guangrong Zheng, Daiqing Liao, Weizhou Zhang, Mei He
Proteolysis targeting chimera extracellular vesicles for therapeutic development treating triple negative breast cancer. bioRxiv : the preprint server for biology (2024)
Yufeng Xiao, Nikee Awasthee, Yi Liu, Chengcheng Meng, Michael Y He, Seth Hale, Rashmi Karki, Zongtao Lin, Megan Mosterio, Benjamin A Garcia, Robert Kridel, Daiqing Liao, Guangrong Zheng
Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8. Journal of medicinal chemistry (2024)
Yufeng Xiao, Nikee Awasthee, Yi Liu, Chengcheng Meng, Michael Y He, Seth Hale, Rashmi Karki, Zongtao Lin, Megan Mosterio, Benjamin A Garcia, Robert Kridel, Daiqing Liao, Guangrong Zheng
Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8. Journal of medicinal chemistry (2024)
Yufeng Xiao, Nikee Awasthee, Yi Liu, Chengcheng Meng, Michael Y He, Seth Hale, Rashmi Karki, Zongtao Lin, Megan Mosterio, Benjamin A Garcia, Robert Kridel, Daiqing Liao, Guangrong Zheng
Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8. Journal of medicinal chemistry 67 (15) (2024)
Yufeng Xiao, Nikee Awasthee, Yi Liu, Chengcheng Meng, Michael Y He, Seth Hale, Rashmi Karki, Zongtao Lin, Megan Mosterio, Benjamin A Garcia, Robert Kridel, Daiqing Liao, Guangrong Zheng
Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8. Journal of medicinal chemistry 67 (15) (2024)
Iqbal Mahmud, Guimei Tian, Jia Wang, Tarun E Hutchinson, Brandon J Kim, Nikee Awasthee, Seth Hale, Chengcheng Meng, Allison Moore, Liming Zhao, Jessica E Lewis, Aaron Waddell, Shangtao Wu, Julia M Steger, McKenzie L Lydon, Aaron Chait, Lisa Y Zhao, Haocheng Ding, Jian-Liang Li, Hamsa Thayele Purayil, Zhiguang Huo, Yehia Daaka, Timothy J Garrett, Daiqing Liao
DAXX drives de novo lipogenesis and contributes to tumorigenesis. Nature communications 14 (1) (2023)
Aaron R Waddell, Iqbal Mahmud, Haocheng Ding, Zhiguang Huo, Daiqing Liao
Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer. Cancers 13 (11) (2021)
Yufeng Xiao, Jia Wang, Lisa Y Zhao, Xinyi Chen, Guangrong Zheng, Xuan Zhang, Daiqing Liao
Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs. Chemical communications (Cambridge, England) 56 (68) (2021)
Aaron R Waddell, Haojie Huang, Daiqing Liao
CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers. Cancers 13 (12) (2021)
Dawei Li, Guimei Tian, Jia Wang, Lisa Y Zhao, Olivia Co, Zoe C Underill, Joe S Mymryk, Frank Claessens, Scott M Dehm, Yehia Daaka, Daiqing Liao
Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survival. The Prostate 78 (15) (2018)
Jude Masannat, Hamsa Thayele Purayil, Yushan Zhang, Michelle Russin, Iqbal Mahmud, Wanju Kim, Daiqing Liao, Yehia Daaka
βArrestin2 Mediates Renal Cell Carcinoma Tumor Growth. Scientific reports 8 (1) (2018)